Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q1 2015 · 10-Q
Revenue$0.00$0.00— vs Q1 2014 Net Income-$416.18K-$416.18KN/M vs Q1 2014 EPS Diluted$0.00$0.00— vs Q1 2014 Operating Income-$403,962N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Free Cash Flowderived-$245,783N/M ended Mar 31, 2015 · filed May 11, 2015 · 41 d after period end